Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Acta Orthop Traumatol Turc ; 42(5): 322-7, 2008.
Artículo en Turco | MEDLINE | ID: mdl-19158452

RESUMEN

OBJECTIVES: We investigated risk factors for venous thromboembolism (VTE), prophylaxis measures employed, and incidence of symptomatic deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing major orthopaedic surgery (MOS). METHODS: An open, multicenter, prospective, observational study was conducted in 21 medical centers, comprising 899 patients. Of these, 316 patients (35.2%) underwent total hip arthroplasty (THA), 328 patients (36.5%) underwent total knee arthroplasty (TKA), and 255 patients (28.4%) underwent surgery for hip fractures (HF). Pharmacologic prophylaxis was employed in all the patients. RESULTS: Risk factors for VTE were seen in 73.2% of the patients, the most common being obesity (72%) and prolonged immobilization (36.3%). Low-molecular-weight heparin (91.1%) and fondaparinux (8.9%) were used for prophylaxis, which was short-term in 273 patients (30.4%) and long-term in 626 patients (69.6%). Mechanical prophylaxis was performed with compression stockings in 610 patients (67.9%) and by intermittent pneumatic compression in 67 patients (7.5%). During three-months of follow-up, symptomatic DVT and PE were seen in eight (0.9%) and four patients (0.4%), respectively. Mortality occurred in 10 patients (1.1%). Complications of major and minor bleeding were seen in eight (0.9%) and 40 (4.5%) patients, respectively. CONCLUSION: Effective VTE prophylaxis is associated with low risk of clinically apparent DVT and PE in MOS.


Asunto(s)
Anticoagulantes/uso terapéutico , Procedimientos Ortopédicos/efectos adversos , Embolia Pulmonar/prevención & control , Tromboembolia Venosa/prevención & control , Anciano , Artroplastia de Reemplazo de Cadera/efectos adversos , Artroplastia de Reemplazo de Rodilla/efectos adversos , Femenino , Fondaparinux , Heparina de Bajo-Peso-Molecular/uso terapéutico , Fracturas de Cadera/cirugía , Humanos , Inmovilización/efectos adversos , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Polisacáridos/uso terapéutico , Estudios Prospectivos , Embolia Pulmonar/epidemiología , Embolia Pulmonar/mortalidad , Factores de Riesgo , Tromboembolia Venosa/epidemiología , Tromboembolia Venosa/mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...